Lumicell, Inc. today announced it is building a commercial team to prepare for market launch of the Lumicell Direct Visualization System (DVS) which includes its novel optical imaging agent LUMISIGHT, upon FDA approval....

Hechler brings more than 15 years of focused life-sciences experience in M&A, strategy, andoperations Newton, Mass., Sept. 16, 2020 – Lumicell, Inc., a leader in image-guided cancer surgery, today announced the addition of Howard Hechler as Senior Vice President of Strategy & Business Development. In this new role, Mr. Hechler will leverage his depth of transactional and operational experience across a range of life sciences technologies to optimize and execute Lumicell’s c...

New location offers more space for expansion and designed to inspire innovation of Lumicell technology through further employee collaboration Newton, Mass., Feb. 22, 2019— Lumicell, Inc., an innovation leader in molecular imaging within healthcare focused in cancer, perfusion, wound care and infection, has expanded into a new headquarters location in Newton, Mass., just outside of Boston. The new office space at One Newton Place, 275 Washington St., is over 20K sq. ft. in size and has been com...

Proceeds to Fund Pivotal Trial in Breast Cancer Leverages Broad Potential of LUM System with Drug, Device and Software for Real-time Detection of Tumor Tissue in Patients During Surgery Wellesley, Mass., Dec. 7, 2017— Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, today provided an update on the company’s development strategy for its LUM system pipeline including plans to initiate its pivotal trial in breast cancer as well as expansion of its clini...

Wellesley, Mass., September 5, 2017— Lumicell, Inc., a technology leader in the field of image-guided cancer surgery, announced today that management will participate in two upcoming September meetings, including:  “We are delighted to represent Lumicell at these important industry meetings and look forward to providing further updates on our progress with the LUM System in the coming weeks,” said Kelly Londy, Chief Executive Officer of Lumicell. About Lumicell, Inc. Lumicell is a tec...

Wellesley, Mass., July 12, 2017 – The Board of Directors of Lumicell, Inc., a leader in the field of image-guided cancer surgery, announced today the appointment of Kelly Londy as Chief Executive Officer and member of the Board of Directors. W. David Lee, Founder of Lumicell, has moved into the role of President and Chief Scientific Officer. Dr. Andrey Zarur, Chairman of the Board of Lumicell, said “We are extremely excited to welcome Kelly to Lumicell. Kelly was chosen as CEO for her p...

Wellesley, Mass., June 28, 2017 – Lumicell, a leader in the field of image-guided cancer surgery, today announced the appointment of Felix Geissler, M.D., Ph.D. as Chief Medical Officer. As a central member of Lumicell’s senior executive team, he will drive the clinical direction of the company and will work closely with the R&D and marketing teams to develop the overall business strategy. Dr. Geissler previously held various roles within Sanofi Genzyme. Most recently, he was t...

Grant will support development of novel image-guided laser ablation system in collaboration with Massachusetts General Hospital, Brigham and Women’s Hospital and Duke University Medical Center Wellesley, Mass., May 14, 2014 – Lumicell, a leader in the field of image-guided cancer surgery, has received a Phase IIB Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The grant will support the company’s expansion into brain and ovarian cancer indic...

Grant will support development of new imaging agents in collaboration with MIT, MGH and       Duke University Medical Center Wellesley, Mass., August 7, 2013 – Lumicell, a leader in the field of image-guided cancer surgery, has received a Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI). The grant will support the company’s pipeline expansion with the development of new imaging agents in collaboration with MIT, Massachusett...

Wellesley, Mass., May 29, 2013 – Lumicell announced it was awarded a $1 million accelerator loan from the Massachusetts Life Sciences Center (MLSC), a quasi-public agency charged with implementing the state’s 10-year, $1-billion Life Sciences Initiative. The MLSC’s Accelerator Loan Program provides loans of up to $1 million to early-stage companies engaged in life sciences research and development, commercialization and manufacturing. “This accelerator loan is of critical importance...